Clinical application and significance of drug delivery systems. Cytokine
Yoshikawa, H.
Nihon Rinsho. Japanese Journal of Clinical Medicine 47(6): 1324-1328
1989
ISSN/ISBN: 0047-1852 PMID: 2671443 Document Number: 344908
Document emailed within 1 workday
Related Documents
Iwaoka, H.; Tsuchida, H.; Makino, H.; Yoshida, S. 1989: Clinical application and significance of drug delivery systems. Insulin injection therapy of diabetes Nihon Rinsho. Japanese Journal of Clinical Medicine 47(6): 1329-1334Okada, H.; Honjo, H. 1989: Clinical application and significance of drug delivery systems. Progestasert, an intrauterine progesterone contraceptive system Nihon Rinsho. Japanese Journal of Clinical Medicine 47(6): 1353-1356
Tsunoda, S.; Tsutsumi, Y.; Mayumi, T. 1998: Molecular design of polymer-conjugated cytokines and its application for drug delivery systems Nihon Rinsho. Japanese Journal of Clinical Medicine 56(3): 573-578
Csaba, N.; Alonso, M.J. 2014: 12. Biodegradable polymer nanoparticles as protein delivery systems: Original research articles: Design of biodegradable particles for protein delivery (2002), Chitosan nanoparticles as delivery systems for doxorubicin (2001); design of microencapsulated chitosan microspheres for colonic drug delivery (1998) Journal of Controlled Release: Official Journal of the Controlled Release Society 190: 53-54
Urquhart, J. 1984: Pharmacological and therapeutic aspects of drug administration by rate-controlled drug delivery systems: steady-state pharmacology Bollettino Chimico Farmaceutico 123(4): 155-168
Shader, R.I.; Greenblatt, D.J. 1997: It's in the bag: drug absorption by drug-delivery systems Journal of Clinical Psychopharmacology 17(5): 339-340
Raynaud, F. 1998: Novel drug delivery systems Idrugs: the Investigational Drugs Journal 1(4): 399-401
Chen, J.-h. 2003: Application of cationic polymer vector for gene delivery systems Yao Xue Xue Bao 38(4): 316-320
Hnatyszyn, H.J.; Kossovsky, N.; Gelman, A.; Sponsler, E. 1994: Drug delivery systems for the future PDA Journal of Pharmaceutical Science and Technology 48(5): 247-254
Sugitachi, A.; Kashiwaba, M.; Shimada, Y.; Terashima, M.; Asahi, H.; Saitoh, K.; Yoshida, Y. 2001: Novel biodegradable materials for drug delivery systems (DDS) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(11): 1530-1533
Inoue, K. 2002: Drug delivery systems for cancer chemotherapy Nihon Geka Gakkai Zasshi 103(2): 224-228
Iga, T. 1989: Injectable and implantable drug delivery systems Nihon Rinsho. Japanese Journal of Clinical Medicine 47(6): 1261-1267
Hogan, B. 2006: The role of filtration in drug delivery systems Medical Device Technology 17(5): 22-24
Conte, U.; Colombo, P.; Caramella, C.; La Manna, A. 1983: The compactability of polymers for drug delivery systems Il Farmaco; Edizione Pratica 38(10): 361-368
Donawa, M. 2000: Drug delivery systems: avoiding the pitfalls Medical Device Technology 11(6): 28-31
Rohan, L.Cencia.; Sassi, A.B. 2009: Vaginal drug delivery systems for HIV prevention Aaps Journal 11(1): 78-87
Caixeta, A.; Abizaid, A.; Aoki, J.; Dangas, G.; Mehran, R. 2008: Future stent drug delivery systems Minerva Cardioangiologica 56(1): 155-166
Senderoff, R.I.; Sheu, M.T.; Sokoloski, T.D. 1991: Fibrin based drug delivery systems Journal of Parenteral Science and Technology: a Publication of the Parenteral Drug Association 45(1): 2-6
Eguchi, K.; Yonezawa, M.; Ohmoto, H.; Hayase, R.; Sekiba, K. 1984: Urinary polyamine analysis and its clinical significance. I. Analysis by HPLC and its clinical application. B. Clinical application to the fields of obstetrics and gynecology Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 59: 38-49
Conte, U.; Colombo, P.; Caramella, C.; La Manna, A. 1984: Press-coated, zero order drug delivery systems Il Farmaco; Edizione Pratica 39(3): 67-75